What is the Historical Analysis of the Preclinical Imaging Market Size?
The preclinical imaging market has seen considerable growth due to a variety of factors.
•The market size for preclinical imaging has seen solid growth in the past few years. It is projected to rise from $3.46 billion in 2024 to $3.69 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 6.7%.
The growth experienced during the historical period can be tied to factors such as government initiatives, the rising incidence of diseases, growing applications, increased awareness, and the development of emerging markets.
What is the Forecasted Growth of the Preclinical Imaging Market Size?
The preclinical imaging market is expected to maintain its strong growth trajectory in upcoming years.
• The market size for preclinical imaging is projected to experience considerable expansion in the forthcoming years, surging to $4.83 billion in 2029 with a compound annual growth rate (CAGR) of 6.9%.
The anticipated growth during this forecast period could be influenced by factors such as the uptake of personalized medicine, progress in molecular imaging, outsourcing drug development, supportive regulatory frameworks, and an increase in chronic diseases. Predominant trends anticipated to unfold during this forecast period encompass green imaging technologies, advancements in technology, R&D activity growth, collaborations and partnerships, and the emergence of real-time imaging.
What Are The Key Drivers Fueling Growth In The Preclinical Imaging Market?
The rise in enduring illnesses is predicted to drive the expansion of the preclinical imaging market. Enduring or chronic diseases are long-term health issues that last for a significant period, typically three months or longer. These conditions often necessitate continuous medical oversight and can greatly affect an individual's life quality. Preclinical imaging instruments are employed for the detection of chronic diseases, offering visualization of the bone structure and lung function. This technique also enables studying chronic diseases by tracking the disease's progression and enhancing disease comprehension. For example, the World Health Organization (WHO) 2022 Highlights, a Swiss-based international health organization, reported in September 2022 that noncommunicable diseases (NCDs) or chronic diseases were responsible for 74% of all global deaths annually, approximately 41 million fatalities. This includes 17.9 million deaths due to cardiovascular diseases, 9.3 million from cancer, 4.1 million from chronic respiratory diseases, and 2.0 million from diabetes. Thus, the increase in chronic disease frequency is fueling the preclinical imaging market's growth.
What Are The Principal Market Segments In The Global Preclinical Imaging Industry?
The preclinical imaging market covered in this report is segmented –
1) By Modality: Optical Imaging Systems, Preclinical Nuclear Imaging Systems, Micro-Magnetic Resonance Imaging Systems, Micro-Ultrasound Systems, Micro-Computed Tomography Systems, Preclinical Photoacoustic Imaging Systems, Preclinical Magnetic Particle Imaging (MPI) Systems
2) By Reagents: Preclinical Optical Imaging Reagents, Preclinical Nuclear Imaging Reagents, Preclinical MRI Contrast Agents, Preclinical Ultrasound Contrast Agents, Preclinical CT Contrast Agents
3) By End User: Hospital, Diagnostics Center, Other End-User
Subsegments:
1) By Optical Imaging Systems: Bioluminescence Imaging, Fluorescence Imaging
2) By Preclinical Nuclear Imaging Systems: Positron Emission Tomography (PET), Single-Photon Emission Computed Tomography (SPECT)
3) By Micro-Magnetic Resonance Imaging (Micro-MRI) Systems: High-Resolution Micro-MRI Systems, Functional Micro-MRI Systems
4) By Micro-Ultrasound Systems: High-Frequency Ultrasound Imaging, Real-Time Micro-Ultrasound Systems
5) By Micro-Computed Tomography (Micro-CT) Systems: In Vivo Micro-CT Systems, Ex Vivo Micro-CT Systems
6) By Preclinical Photoacoustic Imaging Systems: Multi-Wavelength Photoacoustic Imaging, Hybrid Photoacoustic Imaging Systems
7) By Preclinical Magnetic Particle Imaging (MPI) Systems: MPI For Cell Tracking, MPI For Vascular Imaging
Pre-Book The Preclinical Imaging Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
Which Emerging Market Trends Are Altering The Preclinical Imaging Sector?
The trend of product innovation is significantly increasing in popularity within the preclinical imaging market. Many leading firms in this sector are creating innovative products to maintain their market position. For example, in May 2022, Fujifilm VisualSonics Inc., a biomedical company from Canada that specializes in manufacturing imaging systems, introduced Vevo F2 specifically for preclinical imaging. This groundbreaking product is the first of its kind, offering preclinical ultra-high to low-frequency (71 MHz–1 MHz) ultrasonic and photoacoustic imaging facilities. The Vevo F2, equipped with HD image processing capabilities and a unique signal pathway, enhances both image clarity and frame rates. Moreover, its system is flexible enough to be tailored to the precise imaging requirements. Other features include HD image processing technology, new signal pathway, system flexibility, a broad range of anatomical targets and high-resolution imaging, proving it to be apt for diverse research applications.
Who Are the Key Players in the Preclinical Imaging Market?
Major companies operating in the preclinical imaging market include:
• Thermo Fisher Scientific Inc.
• FUJIFILM Visualsonics Inc.
• Konica Minolta Inc.
• Agilent Technologies Inc.
• PerkinElmer Inc.
• Bio-Rad Laboratories Inc.
• Bruker Corporation
• Miltenyi Biotech
• Sofie Biosciences Inc.
• Promega Corporation
• Ion Beam Applications S.A
• Nihon Kohden
• Piramal Enterprises Ltd
• LI-COR Biosciences Inc.
• Aspect Imaging Ltd
• Capintec Inc.
• Spectral Instruments Inc.
• Mediso Ltd
• MR Solutions Ltd
• Biospace Lab S. A.
• Scintica Instrumentation Inc.
• Trifoil Imaging
• Bioscan Inc.
• CytoSMART Technologies B.V
• Inviscan SAS
• Kubtec X-ray
• MILabs B.V.
• SCANCO Medical AG
• Cristal Therapeutics.
What are the Regional Insights into the Preclinical Imaging Market?
North America was the largest region in the preclinical imaging market in 2024. The regions covered in the preclinical imaging market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
